GlaxoSmithKline Consumer Healthcare is Offering free Nicotine Lozenges to all licensed pilots after FAA banned Chantix anti-smoking drug usage due to side effects.

A strong signal of multiple safety problems with Chantix (varenicline), a drug to help people stop smoking, has been seen in a pilot program to identify new drug risks in adverse drug events reported to the U.S. Food and Drug Administration.

Now Viewed as a Mainstream Healthcare Market, Smoking Cessation Drugs Set to Reach $1.5 Billion. Demand Factors, Emerging Products Analyzed by Applied Data Research.